Health care services provider Encompass Health (NYSE:EHC) will be reporting results tomorrow after market close. Here’s what you need to know.
Encompass Health beat analysts’ revenue expectations by 1.8% last quarter, reporting revenues of $1.41 billion, up 12.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ EPS estimates and a narrow beat of analysts’ same-store sales estimates.
Is Encompass Health a buy or sell going into earnings? Read our full analysis here, it’s free .
This quarter, analysts are expecting Encompass Health’s revenue to grow 8.9% year on year to $1.43 billion, slowing from the 13.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.19 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Encompass Health has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.5% on average.
Looking at Encompass Health’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Quest delivered year-on-year revenue growth of 12.1%, beating analysts’ expectations by 1.3%, and Elevance Health reported revenues up 14.8%, topping estimates by 5.3%.
Read our full analysis of Quest’s results here and Elevance Health’s results here .
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link .